These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 7569545)
21. [Hepatitis A vaccination: a sensible luxury?]. Holzer RB Schweiz Rundsch Med Prax; 1993 Feb; 82(7):183-5. PubMed ID: 8382372 [TBL] [Abstract][Full Text] [Related]
22. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on hepatitis prevention. Can Commun Dis Rep; 1997 Sep; 23():1-6. PubMed ID: 9327646 [No Abstract] [Full Text] [Related]
23. Supplementary statement on hepatitis A prevention. Laboratory Centre for Disease Control. CMAJ; 1996 Aug; 155(3):302-5. PubMed ID: 8705911 [No Abstract] [Full Text] [Related]
24. [Prospects for a vaccine against the infectious hepatitis virus]. Panà A Nuovi Ann Ig Microbiol; 1987; 38(1-2):57-79. PubMed ID: 3332810 [No Abstract] [Full Text] [Related]
25. Prevention of hepatitis A virus infection. Moyer L; Warwick M; Mahoney FJ Am Fam Physician; 1996 Jul; 54(1):107-14. PubMed ID: 8677827 [TBL] [Abstract][Full Text] [Related]
26. Active immunization against hepatitis A is now warranted in glucose-6-phosphate dehydrogenase-deficient subjects. Ackerman Z; Ablin J; Shouval D Am J Gastroenterol; 1996 Feb; 91(2):413. PubMed ID: 8607537 [No Abstract] [Full Text] [Related]
28. National Advisory Committee on Immunization (NACI). Statement on the prevention of hepatitis A infections. Can Commun Dis Rep; 1994 Aug; 20(16):133-43. PubMed ID: 7951129 [No Abstract] [Full Text] [Related]
30. International symposium on hepatitis A vaccine. 10 June 1992, Rhodes. Proceedings. J Hepatol; 1993; 18 Suppl 2():S1-71. PubMed ID: 8182264 [No Abstract] [Full Text] [Related]
31. Economic models of hepatitis A virus immunization. O'Connor JB; Imperiale TF; Singer ME Hepatology; 1999 Jul; 30(1):343-5. PubMed ID: 10428627 [No Abstract] [Full Text] [Related]
32. Hepatitis A updated. Yap I Singapore Med J; 1995 Feb; 36(1):23-4. PubMed ID: 7570128 [No Abstract] [Full Text] [Related]
33. Inactivated hepatitis A vaccines. Lemon SM JAMA; 1994 May; 271(17):1363-4. PubMed ID: 8158824 [No Abstract] [Full Text] [Related]
34. [Protection of adolescents against hepatitis A]. Puntarić D; Baklaić Z; Ljubicíc M; Vodopija I Lijec Vjesn; 1996 Oct; 118(10):241-3. PubMed ID: 9132523 [TBL] [Abstract][Full Text] [Related]
35. [Evaluation of immunogenicity and safety in healthy adults of an inactivated anti-hepatitis A vaccine]. Gil A; González A; Dal-Ré ; Aguilar L; Malo C; del Rey J Med Clin (Barc); 1994 May; 102(20):769-71. PubMed ID: 8041214 [TBL] [Abstract][Full Text] [Related]
36. Cell mediated and antibody immune response to inactivated hepatitis A vaccine. Schmidtke P; Habermehl P; Knuf M; Meyer CU; Sänger R; Zepp F Vaccine; 2005 Oct; 23(44):5127-32. PubMed ID: 16054733 [TBL] [Abstract][Full Text] [Related]
37. Anti-hepatitis A virus (HAV) vaccination: guidelines for an immunization strategy in Italy. Workshop Consensus Conference--Rome, May 2-3, 1995. Mele A Ital J Gastroenterol; 1996 Apr; 28(3):181-4. PubMed ID: 8789832 [No Abstract] [Full Text] [Related]